Hepatitis B virus (HBV) is DNA-based virus, member of the Hepadnaviridae family, which
can cause liver disease and increased risk of hepatocellular carcinoma (HCC) in infected …

Viral hepatitis, secondary to infection with hepatitis A, B, C, D, and E viruses, are a major
public health problem and an important cause of morbidity and mortality. Despite the huge …

Primary liver cancer is the fifth most common malignancy and the third leading cause of
cancer death worldwide. Although current advances in the treatment of liver cancer, the …

Hepatocellular carcinoma (HCC) is a prevalent malignancy and there is a lack of effective
biomarkers for HCC diagnosis. Living organisms are complex, and different omics …

Context Astragalus polysaccharide (APS) is a new tumour therapeutic drug, that has an
inhibitory effect on a variety of solid tumours. Tumour cell immunosuppression is related to …

Owing to its heterogeneous and highly aggressive nature, hepatocellular carcinoma (HCC)
has a high recurrence rate, which is a non-negligible problem despite the increasing …

Immature dendritic cells induce immune tolerance and mature dendritic cells induce acute
rejection. We infused bone marrow mesenchymal stem cells (BMMSCs) expressing heme …

Hepatitis D virus (HDV) infection represents the most serious form of chronic hepatitis.
Turkey is among the countries with high HDV and intermediate hepatitis B virus prevalence …

Background Postoperative early recurrence (ER) is a major obstacle to long-term survival
after curative liver resection (LR) in patients with hepatocellular carcinoma (HCC). This study …

Background and aim The impact of currently clinically significant portal hypertension (CSPH)
for patients with early-stage HCC after surgery remains controversial. The purpose of this …